Peptide therapeutics, while one of the fastest growing drug modality, are challenging to formulate, due to heir conformational flexibility, propensity for aggregation and fibrillation, and sensitivity to pH.

In this application note, learn how to:

• Simultaneously assess thermal and colloidal stability to reveal early self-association propensity
• Compare finished-product thermal and colloidal stability across manufacturers and batches
• Characterize pH-dependent solubility and aggregation to inform formulation decisions

Sponsored by